HRP-crosslinked silk–gelatin bioinks: printability dynamics and modulation of stem cell lineage commitment in 3D bioprinted constructs

formulation emerged as the most promising candidate, offering a strategic balance of mechanical integrity, bioactivity, and reproducibility. This optimized enzymatic system paves the way for scalable and clinically viable SF-G bioinks tailored for advanced tissue engineering and regenerative medicine applications.